Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,826 | 3,515 | 4,988 | 3,458 | 5,923 |
| Cost of Goods | 385 | 412 | 302 | 168 | 358 |
| Gross Profit | 1,441 | 3,103 | 4,686 | 3,290 | 5,565 |
| Operating Expenses | 28,273 | 42,391 | 46,783 | 42,360 | 64,890 |
| Operating Income | -26,447 | -38,876 | -41,795 | -38,902 | -58,967 |
| Interest Expense | -1,039 | 0 | -711 | 692 | 747 |
| Other Income | 3,484 | 19,642 | -6,046 | 16,305 | 78,335 |
| Pre-tax Income | -21,924 | -19,234 | -47,130 | -23,289 | 18,621 |
| Income Tax | -1,239 | -7,407 | -346 | 0 | 0 |
| Net Income Continuous | -20,685 | -11,827 | -46,784 | -23,289 | 18,621 |
| Minority Interests | -36 | -118 | -794 | -3,313 | -14,951 |
| Net Income | $-20,649 | $-11,709 | $-45,990 | $-19,976 | $33,572 |
| EPS Basic Total Ops | -0.14 | -0.08 | -0.36 | -0.17 | 0.35 |
| EPS Basic Continuous Ops | -0.14 | -0.08 | -0.37 | -0.20 | 0.19 |
| EPS Diluted Total Ops | -0.14 | -0.08 | -0.36 | -0.17 | 0.34 |
| EPS Diluted Continuous Ops | -0.14 | -0.08 | -0.37 | -0.20 | 0.19 |
| EPS Diluted Before Non-Recurring Items | -0.13 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-24,536 | $-35,747 | $-38,522 | $-34,966 | $-53,762 |